U.S. Retail Distributors Stock News

Wendy's (WEN) shares continue to see subdued trading, with the stock drifting after recent quarterly results and muted market reactions. The fast-food chain's performance over the past month and past 3 months has attracted attention from value-focused investors. See our latest analysis for Wendy's. After a tough year, Wendy's share price has slipped to $8.88, with year-to-date losses deepening and a 1-year total shareholder return of -52.35%. While recent weekly momentum is positive, short-...

Thinking about what to do with Steel Dynamics stock? You are definitely not alone. Whether you've been holding this name for years or just noticed its recent climb, the latest moves have caught the eye of savvy investors and newcomers alike. Let's break down what's going on and set up a deeper dive into whether this stock is a buy, hold, or something else entirely. Steel Dynamics has seen some notable price swings over different timeframes. The past week? Up 1.1%. Over the last month, shares...

Nomad Foods has announced the appointment of Dominic Brisby as its new Executive President, CEO-Elect, and Board member, with a transition period ahead of current CEO Stéfan Descheemaeker’s retirement on January 1, 2026. The succession introduces a leader with a history of revitalizing consumer goods companies, signaling a potential shift in Nomad Foods’ strategic direction and innovation capabilities. We'll examine how leadership continuity and the appointment of an experienced industry...

NCR Voyix is partnering with Corpay to bring new payment acceptance options to its point-of-sale systems for commercial fuel transactions. This deal, which taps into Corpay's Comdata network, could influence how over 18,000 fuel stations process fleet card transactions. See our latest analysis for NCR Voyix. NCR Voyix’s latest partnership comes as its shares trade at $11.29, with momentum taking a hit over the past month. The 30-day share price return is -11.7%, and a one-year total...

Lennar (LEN) has joined several other national builders in introducing new buyer incentives and promotions to address the challenges of higher home prices and interest rates. Recent policy attention toward supporting big homebuilders is also in the spotlight. See our latest analysis for Lennar. Lennar’s year has been marked by brisk news, from launching new communities like River Bridge Ranch in Texas to drawing fresh investor attention and even a notable exchange offer with Millrose...

Cohen & Steers (NYSE:CNS) drew attention after releasing third quarter results that beat expectations for both revenue and profit. Shares jumped as investors responded to stronger than expected figures and multiyear high net inflows. See our latest analysis for Cohen & Steers. Despite today’s jump, Cohen & Steers’ 1-day share price return of 5.8% reflects a welcome change in momentum after a challenging start to the year. Over the past twelve months, the stock’s total shareholder return was...

Fastly (FSLY) shares slipped about 1% today, with the move coming quietly and without a major headline catalyst. Investors may be watching the stock’s valuation and recent price trends, especially after some recent volatility. See our latest analysis for Fastly. Fastly’s share price has been trending lower over the last month, wiping out nearly 9% in the past 30 days. However, it remains up more than 10% for the past 90 days. Despite short-term volatility, its 1-year total shareholder return...

Trying to figure out what’s next for PTC Therapeutics? You’re not alone. Whether you’re holding shares, eyeing an entry, or just want to keep tabs on one of biotech’s more intriguing players, let’s dig in. Over the past month, the stock has put on a show, rising 8.7%. Zoom out a bit further and you’ll spot a year-to-date surge of 43.7%, with a hefty 68.7% jump over the past year. That’s more than just a good run, and it has caught the market’s attention, especially as broader industry...

Expeditors International of Washington has recently surpassed earnings estimates for two consecutive quarters, with analysts currently holding a positive Earnings ESP of +3.42% ahead of its next earnings report expected on November 4, 2025. This consistent outperformance and rising analyst optimism reflect increased confidence in the company's near-term financial prospects. We'll explore how positive analyst sentiment, spurred by recent earnings beats, shapes Expeditors International's...

Arthur J. Gallagher (AJG) shares have been moving in recent weeks, catching the attention of investors tracking the insurance sector. The stock has seen mixed returns across different timeframes, making it a topic of discussion among market watchers. See our latest analysis for Arthur J. Gallagher. Arthur J. Gallagher’s share price has slipped around 4% over the past month and is now up just 1.7% year to date, suggesting the recent momentum has cooled a bit despite earlier resilience. Looking...

Deciding what to do with Skyworks Solutions’ stock right now? You are definitely not alone. After all, it has been a bit of a roller coaster ride lately. In the past week alone, shares jumped 8.9%, giving investors a reason to look twice. Still, if you take a step back and look at a longer timeline, things appear more complicated. The stock is down 14.8% since the start of the year and has fallen a substantial 20.7% over the last 12 months. The five-year track shows a 43.2% drop, even as the...

Otis Worldwide (NYSE:OTIS) is in focus after its Indian subsidiary signed a major deal to deliver 169 next-generation elevator systems for three luxury residential projects in Hyderabad, further expanding its presence in India’s premium housing sector. See our latest analysis for Otis Worldwide. Despite Otis Worldwide’s impressive contract wins and growing global footprint, investors have seen the company’s momentum fade this year. The share price closed at $91.29 and delivered a 12.4% drop...

On October 8, 2025, Tarang Sharma, Chief Accounting Officer of VSE Corporation, notified the company of his decision to resign effective October 31, 2025, to pursue an opportunity outside the Aviation industry and will provide transitional consulting services through March 2026. The company stated that Mr. Sharma's departure is not due to any disagreement regarding VSE’s operations or financial reporting, indicating stability in leadership practices during the transition. Given Mr. Sharma’s...

Arm Holdings (NasdaqGS:ARM) is capturing attention as it deepens its presence in artificial intelligence through high-profile partnerships, notably teaming up with Meta Platforms to power AI systems on Facebook and Instagram. See our latest analysis for Arm Holdings. Bullish sentiment toward Arm has been building thanks to headline-making partnerships and new collaborations focused on AI and infrastructure development. After a run of major news, Arm’s year-to-date share price return of 29%...

Harrow (HROW) is drawing increased attention following recent news of its debt refinancing, plans to acquire Melt Pharmaceuticals, and new peak sales projections that point to strong revenue growth over the next decade. See our latest analysis for Harrow. Harrow’s recent streak of newsworthy events appears to be resonating with investors, as momentum has picked up following the debt refinancing and acquisition plans. While the company’s 5.51% share price return over the last day suggests...

Elanco Animal Health (NYSE:ELAN) is preparing for its Investor Day on December 9, 2025. Senior leaders are scheduled to discuss the company’s strategy, innovation plans, and financial outlook. Investors are watching closely for new insights. See our latest analysis for Elanco Animal Health. Momentum has picked up in a big way for Elanco this year, with the share price racing ahead for a 77.8% year-to-date return that far outpaces the broader sector. While some of this surge reflects renewed...

Exelixis (EXEL) just shared new results from a subgroup analysis of its phase 3 CABINET trial. The study showed that CABOMETYX substantially reduced disease progression or death in patients with advanced neuroendocrine tumors of the lung or thymus. See our latest analysis for Exelixis. Exelixis has been on investors’ radar thanks to regulatory milestones and encouraging trial updates like the new CABINET data. That buzz is showing up in the numbers, with a 15.7% year-to-date share price...

Federal Home Loan Mortgage (FMCC) is drawing fresh attention as average 30-year fixed mortgage rates moved down to 6.27% this week. Refinancing activity and housing affordability are seeing an uptick. Ongoing policy discussions could further influence its trajectory. See our latest analysis for Federal Home Loan Mortgage. This easing in mortgage rates has arrived alongside several noteworthy updates from Freddie Mac, including a leadership change and the purchase of $1.2 billion in credit...

MercadoLibre (NasdaqGS:MELI) has recently rolled out a business-to-business e-commerce platform in Brazil, Argentina, Mexico, and Chile, while also moving into Brazil’s online pharmacy space. These fresh initiatives, along with momentum in MercadoPago and logistics investments, are sparking new interest in the stock. See our latest analysis for MercadoLibre. MercadoLibre’s bold regional moves have made headlines, but this energy hasn’t shielded investors from volatility. After strong gains...

Bragar Eagel & Squire, P.C. announced an investigation into Amylyx Pharmaceuticals following a class action complaint alleging the company’s board made misleading statements about the demand and commercial viability of its ALS drug, Relyvrio. This development draws fresh attention to the company's disclosures and how they communicate the prospects and performance of their key product to investors. We’ll take a closer look at how concerns over transparency and Relyvrio’s commercial outlook...

Spotify recently announced a sweeping collaboration with Warner Music Group, Sony Music Group, Universal Music Group, and others to develop responsible AI-powered music products that prioritize artist rights and copyright protection. This joint initiative addresses both opportunities and risks associated with generative AI, aiming to shape industry standards for fair compensation, consent, and innovation in music creation. Let's examine how Warner Music Group's involvement in shaping...

Dogness (International) (DOGZ) remains unprofitable, with losses having grown at a compounded rate of 13.9% annually over the past five years. The company’s net profit margin has failed to improve, and there are no signs of a turnaround or positive profit growth in recent periods. See our full analysis for Dogness (International). Next, we will see how the latest numbers measure up against the key narratives followed by the market. We will also consider whether popular views on DOGZ are still...

In recent days, Organon reported that persistent revenue declines over the past five years have been compounded by a sharper drop in earnings per share as customers delayed purchases. This ongoing operational challenge signals deep-rooted issues in demand and profitability, extending beyond temporary market disruptions or isolated quarters. With customer purchase delays amplifying already declining revenues, we’ll assess how this trend affects Organon’s investment narrative and outlook...

Apivia Courtage recently announced a collaboration with SoundHound AI to implement the Amelia 7 agentic AI platform in its contact centers as part of a broader digital transformation strategy, aiming to automate complex customer service tasks while enabling seamless self-serve experiences. This deployment builds upon previous gains in productivity from earlier AI adoption and marks one of the insurance sector's first enterprise-scale uses of advanced agentic capabilities for customer-facing...